Lightnews — Scholar-powered news

New Review in TCRT: Whole-body MRI offers a radiation-free alternative for staging, monitoring and follow-up in lymphoma, highlighting safer imaging for children and pregnant patients.

Read the article: journals.sagepub.com/doi/10.1177/...

@journals.sagepub.com

#Lymphoma #Oncology

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

August 18, 2025 at 12:31 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

Newly published in TCRT@tcrtcancer.bsky.social: Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems

doi.org/10.1177/1533...

@journals.sagepub.com @oncodaily.bsky.social

#LungCancer #CancerResearch #EarlyDetection

Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems - Anu Maria Sebastian, David Peter, T. P. Rajagopal, Rinu Ann Sebastian, 2025

Introduction Lung cancer has the highest mortality rate among all cancer types globally, largely due to delayed or ineffective diagnosis and treatment. Radiomic...

doi.org

August 14, 2025 at 9:40 AM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

📢 New in TCRT @tcrtcancer.bsky.social: Researchers from #UTSouthwestern & RefleXion tested biology-guided radiotherapy (BgRT) beyond lung & bone cancers, creating PET-based plans for multiple cancer sites using RefleXion X1 with SCINTIX® tech, and all deemed clinically acceptable.

bit.ly/45bUulJ

Expanding SCINTIX Biology-Guided Radiotherapy Beyond Lung and Bone: A Planning Feasibility and Dosimetric Study on the RefleXion X1 System - Haozhao Zhang, Grant Gibbard, Chenyang Shen, Thomas I. Bank...

Introduction SCINTIX® therapy, a form of biology-guided radiotherapy using real-time positron emission tomography (PET) imaging on the RefleXion® X1 platform, r...

bit.ly

August 11, 2025 at 10:54 AM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New article published in @tcrtcancer.bsky.social shows how transcriptomic-based prognostic tests can improve recurrence risk prediction in papillary thyroid cancer.
@journals.sagepub.com

Read the full article: bit.ly/3ITzE1P

#ThyroidCancer #MolecularDiagnostics #CancerBiomarkers #OncoDaily

August 1, 2025 at 2:46 PM

Reposted by Technology in Cancer Research & Treatment (IF 2.8)

Applonia Rose

@apploniarose.bsky.social

New article published in @tcrtcancer.bsky.social shows how transcriptomic-based prognostic tests can improve recurrence risk prediction in papillary thyroid cancer. @journals.sagepub.com

Read the full article here: bit.ly/3ITzE1P

#ThyroidCancer #MolecularDiagnostics #CancerBiomarkers #OncoDaily

August 1, 2025 at 2:38 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

Why publish with Technology in Cancer Research & Treatment? @tcrtcancer.bsky.social

🔍Researchers value our fair and efficient review process. Hear directly from authors about their experience: bit.ly/457bwQF

@journals.sagepub.com
#CancerResearch #Oncology #OpenAccess #OncoDaily

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

July 30, 2025 at 5:38 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New in @tcrtcancer.bsky.social: A Translational Research Leveraging Diagnostic Accuracy of Innovations in MRI as a Model for Early Breast Cancer Detection in Uganda.

#BreastCancer #MRI #CancerResearch #OncoDaily

Read the article here:
journals.sagepub.com/doi/10.1177/...

A Translational Research Leveraging Diagnostic Accuracy of Innovations in MRI as a Model for Early Breast Cancer Detection in Uganda - Alfred Bulamu, Gregory S. Karczmar, Funmi Olopade, Zhen Ren, Vice...

Introduction Breast cancer remains a leading cause of cancer-related morbidity and mortality in sub-Saharan Africa, with Uganda experiencing a reported 5% annua...

journals.sagepub.com

July 15, 2025 at 5:08 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New in @tcrtcancer.bsky.social: A novel HER2-targeted nanoliposome therapy shows promise in overcoming immunotherapy resistance in HER2+ breast cancer by turning “cold” tumors hot.
Read here: bit.ly/451i7gH
@journals.sagepub.com

#CancerResearch #BreastCancer #Immunotherapy #HER2 #OncoDaily

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

July 14, 2025 at 8:53 AM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

Electrochemotherapy for Anorectal Tumors: A Narrative Literature Review @tcrtcancer.bsky.social @journals.sagepub.com
#CancerResearch #Oncology #Electrochemotherapy
#AnorectalCancer #CancerTreatment #openaccess

journals.sagepub.com/doi/10.1177/...

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

July 8, 2025 at 3:58 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

Join TCRT as a Section Editor!
Make an impact in Cancer Biology, Detection, Diagnosis & Treatment.
🌟 IF 2.8 | Q2 Oncology | 600K+ downloads/year |500+ Board members
Read more: bit.ly/4lBVOn9
Apply here: bit.ly/4nu0eye

@tcrtcancer.bsky.social @drjkyl.bsky.social @journals.sagepub.com

#Oncology

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

July 3, 2025 at 3:54 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

We’re inviting you to contribute to our Special Collection: The Role of Technological Advances in Shaping the Future of Liver Cancers, led by Dr. Georgios Tsoulfas.

June 19, 2025 at 3:40 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New Review published in @tcrtcancer.bsky.social explores the role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy.

#CancerResearch #Lymphoma #Oncology #Radiotherapy
@journals.sagepub.com @oncodaily.bsky.social

journals.sagepub.com/doi/full/10....

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review - Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, Luca Trigg...

Introduction Historically, the management of relapsed or refractory diffuse large B-cell lymphoma (r/r-DLBCL) involved chemotherapy and autologous stem cell tra...

journals.sagepub.com

June 19, 2025 at 12:16 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

🎉 Exciting news! TCRT is now ranked Q2 in Oncology in the latest JCR - a first for us! Huge thanks to our authors, editors & reviewers for making it happen.

Keep advancing cancer research with us: bit.ly/43QY0Bm

#Oncology @tcrtcancer.bsky.social @journals.sagepub.com @oncodaily.bsky.social

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

June 18, 2025 at 11:08 AM

Reposted by Technology in Cancer Research & Treatment (IF 2.8)

Jen L, PhD

@drjkyl.bsky.social

Percutaneous Locoregional Therapies for the Treatment of Liver Metastases from Uveal Melanoma: A Systematic Review
@journals.sagepub.com @tcrtcancer.bsky.social

journals.sagepub.com/doi/10.1177/...

#cancermetastasis #cancerresearch #oncology #oncsky #openaccess @oncodaily.bsky.social

June 6, 2025 at 7:07 PM

Reposted by Technology in Cancer Research & Treatment (IF 2.8)

Jen L, PhD

@drjkyl.bsky.social

Streamlining Thoracic Radiotherapy Quality assurance: One-Class Classification for Automated OAR Contour Assessment
@journals.sagepub.com @tcrtcancer.bsky.social

journals.sagepub.com/doi/10.1177/...

#radiationtreatment #treatmentplanning #cancertreatment #oncology #onsky #openaccess

May 29, 2025 at 9:59 PM

Reposted by Technology in Cancer Research & Treatment (IF 2.8)

Jen L, PhD

@drjkyl.bsky.social

Machine Learning Model Integrating CT Radiomics of the Lung to Predict Checkpoint Inhibitor Pneumonitis in Patients with Advanced Cancer
@journals.sagepub.com @tcrtcancer.bsky.social

journals.sagepub.com/doi/10.1177/...

#artificialintelligence #adverseevent #immunecheckpointinhibitors #openaccess

May 29, 2025 at 10:04 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

⏱️ Time Matters in Radiotherapy
Delays in treatment can affect patient outcomes and clinic operations. A new review in @tcrtcancer.bsky.social maps where time is lost and how streamlining workflows can improve care.

Read the article here: journals.sagepub.com/doi/full/10....

#Radiotherapy #Oncology

May 28, 2025 at 6:20 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New systematic review published in @tcrtcancer.bsky.social explores Percutaneous Locoregional Therapies for the Treatment of Liver Metastases from Uveal Melanoma.
Read the article here: doi.org/10.1177/1533...
@journals.sagepub.com @University of Catania
#MelanomaAwareness #InterventionalOncology

Percutaneous Locoregional Therapies for the Treatment of Liver Metastases from Uveal Melanoma: A Systematic Review - Corrado Ini', Pietro Valerio Foti, Renato Farina, Francesco Tiralongo, Davide Giuse...

Introduction The prognosis of patients with uveal melanoma is related to several factors, including local or extraocular extension of the disease. Up to 50% of ...

doi.org

May 27, 2025 at 6:08 PM

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

🔬 New #CallForPapers from Tech in Cancer Research & Treatment!
We're spotlighting imaging in women’s health, from biopsies to MRI to tumoroids. If you're working on novel or gold-standard imaging in female cancer research, we want to hear from you.
Guest Editor: Dr Anna Schueth